FIELD: medicine.
SUBSTANCE: for diagnostics and therapy of malignant tumors 10% ascorbate ferrite or citrate ferrite sol from 0.02 ml to 0.2 ml in polyglukin is introduced to animals with implanted tumors intravenously. After that magnevist is introduced. Magnetic-resonance tomography is performed, obtaining T1 T2 and T2*-suspended 3D images.
EFFECT: method allows to increase visibility, brightness and duration of MRT-images of tumor-feeding vessels.
6 ex, 1 dwg, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF DIAGNOSTICS OF ONCOLOGIC DISEASES IN EXPERIMENT | 2007 |
|
RU2343828C2 |
| MEANS AND METHOD FOR EARLY EXPERIMENTAL CONTRAST MAGNETIC-RESONANCE TOMOGRAPHIC DETECTION OF MALIGNANT GLIAL TUMORS WITH FEEDING VESSELS | 2016 |
|
RU2655303C2 |
| AGENT FOR EARLY CONTRAST DETECTION OF MALIGNANT PROLIFERATION CENTERS WITH FEEDING VESSELS, BOUNDARIES OF DIFFUSE INFILTRATION AND DETERMINATION OF STAGES OF THEIR DEVELOPMENT IN DYNAMICS | 2017 |
|
RU2692579C2 |
| MEANS AND METHOD FOR COMBINED CONTRAST ENHANCED MAGNETIC RESONANCE IMAGING IMAGE VISUALIZATION OF BIOMECHANICS OF THE PROCESSES OF INFILTRATION, INVASION AND METASTASIS OF MALIGNANT CELLS | 2020 |
|
RU2761827C1 |
| METHOD OF NONINVASIVE QUALITATIVE AND QUANTITATIVE ANALYSIS OF MAGNETOCONTROLLABLE NANOMEDICINES AND REAL-TIME FUNCTION EVALUATION IN EXPERIMENTAL ANIMALS | 2009 |
|
RU2427390C2 |
| DIAGNOSTIC TECHNIQUE FOR GLIOBLASTOMA MULTIFORME BY MAGNETIC RESONANCE TOMOGRAPHY | 2012 |
|
RU2530762C2 |
| GADOPENTETATE-MODIFIED BETA-CYCLODEXTRIN DERIVATIVES | 2013 |
|
RU2541090C1 |
| METHOD OF FERRIMAGNETIC-THERMOCHEMOTHERAPY OF MALIGNANT TUMOURS WITH COMBINATIONS OF MAGNETOCONTROLLABLE NANOMEDICINES WITH VISUALISATION OF ONCOGENESIS, DETEMINATION OF THERAPY PREFERABLE IN REAL TIME MODE AND MONITORING OF TREATMENT RESULTS IN EXPERIMENT | 2014 |
|
RU2563369C1 |
| CONTRASTING AGENT FOR MAGNETIC-RESONANCE DIAGNOSTICS OF TUMOURS | 2008 |
|
RU2385152C1 |
| CONTRAST AGENT FOR MAGNETIC RESONANCE TOMOGRAPHY | 2011 |
|
RU2465010C1 |
